Form 485BXT RUSSELL INVESTMENT FUNDS

Filed Pursuant to Rule 485(b) 

Registration No.   033-18030

811-05371

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-1A

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933			X
Pre-Effective Amendment No.
Post-Effective Amendment No.  90			X
and
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940			X
Amendment No.  93			X

 

RUSSELL INVESTMENT FUNDS

 

(Exact Name of Registrant as Specified in Charter)

1301 Second Avenue, 18^th Floor, Seattle, Washington  98101

(Address of Principal Executive Office)       (ZIP Code)

Registrant’s Telephone Number, including area code: 206/505-7877

 

Mary Beth Rhoden Albaneze, Esq.		John V. O’Hanlon, Esq.
Associate General Counsel		Dechert LLP
Russell Investment Funds		One International Place, 40th Floor
1301 Second Avenue, 18th Floor		Boston, Massachusetts 02110
Seattle, Washington 98101		617-728-7100
206-505-4846

 

 

(Name and Address of Agent for Service)

Approximate date of commencement of proposed public offering: As soon as practical after the effective date of the Registration Statement.

It is proposed that this filing will become effective (check appropriate box)

(  ) immediately upon filing pursuant to paragraph (b)

( X ) on May 1, 2024 pursuant to paragraph (b)

(  ) 60 days after filing pursuant to paragraph (a)(1)

(  ) on          , pursuant to paragraph (a)(1)

(  ) 75 days after filing pursuant to paragraph (a)(2)

(  ) on (date) pursuant to paragraph (a)(2) of rule 485.

If appropriate, check the following box:

( X ) this post-effective amendment designates a new effective date for a

previously filed post-effective amendment.

---

PART A, PART B and PART C

The Registrant hereby incorporates in its entirety each of Part A, Part B and Part C of Post-Effective Amendment No. 89 to Registration Nos. 033-18030 and 811-05371 into, and hereby designates each such Part as constituting in its entirety Part A, Part B and Part C, respectively, of Post-Effective Amendment No. 90 to Registration Nos. 033-18030 and 811-05371. This Post-Effective Amendment No. 90 is being filed to extend the effective date of previously filed Post-Effective Amendment No. 89. The Registrant’s updated Prospectus, Statement of Additional Information and Other Information will be filed pursuant to 485(b) on or before May 1, 2024.

---

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant, Russell Investment Funds, certifies that it meets all of the requirements for effectiveness of this Registration Statement pursuant to Rule 485(b) of the Securities Act of 1933. The Registrant has duly caused this Post-Effective Amendment No. 90 to its Registration Statement to be signed on its behalf by the undersigned thereto duly authorized, in the City of Seattle, and State of Washington, on this 5^th day of April, 2024.

 

 

 

/s/ Jessica Gates

* By Jessica Gates

Attorney-in-fact

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities indicated on April 5, 2024.

 

Signatures				Signatures
*				*
Kari Seabrands, Treasurer, Chief				Vernon Barback, Trustee, President and
Financial Officer (Principal Financial				Chief Executive Officer (Principal Executive
Officer) and Chief Accounting Officer				Officer)
(Principal Accounting Officer)
*				*
Michelle Cahoon, Trustee				Michael Day, Trustee
*				*
Julie Dien Ledoux, Trustee				Jeremy May, Trustee
*				*
Jeannie Shanahan, Trustee				Raymond P. Tennison, Jr., Trustee
*
Jack R. Thompson, Trustee

---

/s/ Jessica Gates

*By Jessica Gates

Attorney-in-fact

 

*	Executed pursuant to powers of attorney filed with Post-Effective Amendment No. 89 to Registration Statement File Nos. 033-18030 and 811-05371.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Kennedy Wilson Announces Add-On Senior Notes Offering
• ManpowerGroup Reports 2nd Quarter 2026 Results
• Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio